Neuro Rx

Based in Montreal, Canada, NeuroRx engages with pharmaceutical industry partners in undertaking clinical trials for medications related to neurological diseases such as multiple sclerosis. NeuroRx utilizes state-of-the-art image analysis techniques in generating precisely calibrated results that enhance the accuracy of studies. NeuroRx facilitates MRI trial activities in a manner that complies with all regulations and effectively manages scan tracking and handling. The NeuroRx team adjusts images for factors such as inhomogeneity and ensures high precision and proper re-alignment through co-registering.

NeuroRx capacities extend to non-conventional MRI operations, such as magnetic resonance spectroscopy and magnetization transfer imaging. NeuroRx was involved in a long-term study of patients who received Genzyme's Lemtrada treatment. MRI effects were presented at the 66th American Academy of Neurology conference and indicated that Lemtrada treatment continued to be effective years after the last dose.